Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120686254 | 12068625 | 4 | F | 20150526 | 20160428 | 20160211 | 20160815 | EXP | DK-OTSUKA-2015_013551 | OTSUKA | 21.14 | YR | M | Y | 0.00000 | 20160815 | CN | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120686254 | 12068625 | 1 | PS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, EVERY 4TH WEEK | Y | U | 202971 | 400 | MG | SUSPENSION FOR INJECTION | |||||
| 120686254 | 12068625 | 2 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Y | U | 202971 | SUSPENSION FOR INJECTION | |||||||||
| 120686254 | 12068625 | 3 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Y | U | 202971 | SUSPENSION FOR INJECTION | |||||||||
| 120686254 | 12068625 | 4 | C | DELEPSINE | DIVALPROEX SODIUM | 1 | Unknown | 1500 MG, QD | 0 | 1500 | MG | QD | |||||||
| 120686254 | 12068625 | 5 | C | OXAPAX | OXAZEPAM | 1 | Unknown | 15 MG, PN 2 X 1 | 0 | 15 | MG | TABLET | |||||||
| 120686254 | 12068625 | 6 | C | OXAPAX | OXAZEPAM | 1 | Unknown | 15 MG, PN 2 X 1 | 0 | 15 | MG | TABLET | |||||||
| 120686254 | 12068625 | 7 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | 100 MG, UNK | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120686254 | 12068625 | 1 | Psychotic behaviour |
| 120686254 | 12068625 | 2 | Psychotic behaviour |
| 120686254 | 12068625 | 3 | Akathisia |
| 120686254 | 12068625 | 4 | Product used for unknown indication |
| 120686254 | 12068625 | 5 | Product used for unknown indication |
| 120686254 | 12068625 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120686254 | 12068625 | OT |
| 120686254 | 12068625 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120686254 | 12068625 | Aggression | |
| 120686254 | 12068625 | Drug ineffective | |
| 120686254 | 12068625 | Off label use | |
| 120686254 | 12068625 | Pain in extremity | |
| 120686254 | 12068625 | Psychotic disorder | |
| 120686254 | 12068625 | Restlessness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120686254 | 12068625 | 1 | 20150526 | 20151125 | 0 |